AVXL INVESTOR DEADLINE: Robbins Geller Rudman & Dowd LLP Announces that Anavex Life Sciences Corporation Investors with Substantial Losses Have Opportunity to Lead Case
Anavex Life Sciences (AVXL) Newsfilter·2024-04-25 05:25SAN DIEGO, April 24, 2024 (GLOBE NEWSWIRE) -- Robbins Geller Rudman & Dowd LLP announces that purchasers or acquirers of Anavex Life Sciences Corporation (NASDAQ:AVXL) stock between February 1, 2022 and January 1, 2024, inclusive (the "Class Period"), have until May 13, 2024 to seek appointment as lead plaintiff of the Anavex class action lawsuit. Captioned Blum v. Anavex Life Sciences Corporation, No. 24-cv-01910 (S.D.N.Y.), the Anavex class action lawsuit charges Anavex as well as Anavex executives with v ...